Ordering
Available Variants10 mg
CHA.57349-10mg
Price
€165.60
Available – Dispatch in 14 days
25 mg
CHA.57349-25mg
Price
€370.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
10 mg | CHA.57349-10mg | €165.60 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.57349-25mg | €370.40 |
≥98% (HPLC), Antiangeogenic reagent, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C18H18O2 |
|---|---|
| CAS Number | 35354-74-6 |
| Molecular Weight | 266.33 |
| UNSPSC Code | 12352200 |
| PubChem Substance ID | 24724501 |
| NACRES | NA.77 |
| MDL number | MFCD00016674 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
| Storage condition | desiccated |
Safety Information Handling visibility
| pictograms |
GHS05
GHS09
  GHS05,GHS09
|
|---|---|
| signalword | Danger |
| hcodes | H318,H411 |
| pcodes | P273 - P280 - P305 + P351 + P338 - P391 - P501 |
| Hazard Classifications | Aquatic Chronic 2 - Eye Dam. 1 |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | dust mask type N95 (US), Eyeshields, Gloves |
Technical Overview & Applications Use-case context
Honokiol, a biphenolic compound with the CAS number 35354-74-6, is a lignan isolated from the bark, seed cones, and leaves of the Magnolia tree. It has been extensively studied for its diverse range of biological activities, including anti-inflammatory, antioxidant, and anticancer properties. Honokiol has been shown to modulate various signaling pathways, leading to the inhibition of cell growth and induction of apoptosis in cancer cells. Additionally, it exhibits neuroprotective effects by reducing oxidative stress and inflammation in the brain. The compounds unique mechanism of action and low toxicity profile make it a promising candidate for the development of therapeutic agents for the treatment of various diseases, including cancer, neurodegenerative disorders, and inflammatory conditions. Further research is needed to fully explore the potential of honokiol as a pharmacologically active agent.
